Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
16 Apr 2024 |
MA |
Memorandum and Articles of Association
|
|
|
16 Apr 2024 |
SH02 |
Sub-division of shares on 4 April 2024
|
|
|
16 Apr 2024 |
SH01 |
Statement of capital following an allotment of shares on 4 April 2024
|
|
|
16 Apr 2024 |
RESOLUTIONS |
Resolutions
-
RES13 ‐
The company's existing 90,000 issued ordinary shares of £0.0001 each be subdivided into 9,000,000 ordinary shares of £0.000001 each 04/04/2024
-
RES12 ‐
Resolution of varying share rights or name
-
RES10 ‐
Resolution of allotment of securities
-
RES11 ‐
Resolution of removal of pre-emption rights
-
RES01 ‐
Resolution of adoption of Articles of Association
|
|
|
16 Apr 2024 |
SH08 |
Change of share class name or designation
|
|
|
03 Apr 2024 |
CS01 |
Confirmation statement made on 21 March 2024 with no updates
|
|
|
05 Mar 2024 |
AA |
Total exemption full accounts made up to 31 August 2023
|
|
|
30 May 2023 |
AA |
Unaudited abridged accounts made up to 31 August 2022
|
|
|
05 Apr 2023 |
CS01 |
Confirmation statement made on 21 March 2023 with no updates
|
|
|
10 Aug 2022 |
AD01 |
Registered office address changed from Innovation Gateway (The London Cancer Hub) Cotswolds Road Sutton Surrey SM2 5NG United Kingdom to Innovation Gateway (The London Cancer Hub) Cotswold Road Sutton Surrey SM2 5NG on 10 August 2022
|
|
|
13 Jun 2022 |
AD01 |
Registered office address changed from Innovation Gateway the London Cancer Hub Cotswold Road Sutton SM2 5NF England to Innovation Gateway (The London Cancer Hub) Cotswolds Road Sutton Surrey SM2 5NG on 13 June 2022
|
|
|
03 May 2022 |
AD01 |
Registered office address changed from London Cancer Hub Innovation Gateway Cotswold Road Sutton SM2 5NF England to Innovation Gateway the London Cancer Hub Cotswold Road Sutton SM2 5NF on 3 May 2022
|
|
|
03 May 2022 |
AD01 |
Registered office address changed from Vesynta Ltd C/O Ucl Department of Chemical Engineering Torrington Place London WC1E 7JE England to London Cancer Hub Innovation Gateway Cotswold Road Sutton SM2 5NF on 3 May 2022
|
|
|
23 Mar 2022 |
CH01 |
Director's details changed for Mr Alaric William Taylor-Roffey on 14 March 2022
|
|
|
23 Mar 2022 |
PSC04 |
Change of details for Mr Alaric William Taylor-Roffey as a person with significant control on 25 February 2022
|
|
|
21 Mar 2022 |
CS01 |
Confirmation statement made on 21 March 2022 with updates
|
|
|
21 Mar 2022 |
PSC07 |
Cessation of Stefan Guldin as a person with significant control on 18 March 2022
|
|
|
17 Mar 2022 |
CS01 |
Confirmation statement made on 3 March 2022 with no updates
|
|
|
16 Jan 2022 |
TM01 |
Termination of appointment of Stefan Guldin as a director on 10 January 2022
|
|
|
01 Dec 2021 |
AA |
Micro company accounts made up to 31 August 2021
|
|
|
14 Jun 2021 |
AD01 |
Registered office address changed from Vesynta Ltd C/O Ucl Department of Engineering Torrington Place London WC1E 7JE England to Vesynta Ltd C/O Ucl Department of Chemical Engineering Torrington Place London WC1E 7JE on 14 June 2021
|
|
|
14 Jun 2021 |
AD01 |
Registered office address changed from 5 Naseby Road Upper Norwood London SE19 3JJ to Vesynta Ltd C/O Ucl Department of Engineering Torrington Place London WC1E 7JE on 14 June 2021
|
|
|
31 Mar 2021 |
AA |
Micro company accounts made up to 31 August 2020
|
|
|
16 Mar 2021 |
CS01 |
Confirmation statement made on 3 March 2021 with no updates
|
|
|
29 Apr 2020 |
AA01 |
Current accounting period shortened from 1 September 2020 to 31 August 2020
|
|